Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of positron emission tomography within the spectrum of medical imaging.

Literature DB >> 8925858

The role of positron emission tomography within the spectrum of medical imaging.

Abstract

The aim of the survey is to help to define the role of positron emission tomography (PET) as an investigative procedure, and to identify strategies to perfect PET and in vivo tracer studies in general so that their full potential is realised. Within this context, the sensitivity and specificity of PET are reviewed. The impact of PET through studies of regional cerebral activation based on blood flow measurements is discussed. Emphasis is placed on the role of PET in clinical research and as a means of assessing new therapeutic agents. This latter ability renders PET of much interest to pharmaceutical companies.

Mesh：

Year: 1996 PMID： 8925858 DOI： 10.1007/bf01731847

Source DB: PubMed Journal: Eur J Nucl Med ISSN： 0340-6997

13 in total

1. Quantitative measurement of monoclonal antibody distribution and blood flow using positron emission tomography and 124iodine in patients with breast cancer.

Authors: C B Wilson; D E Snook; B Dhokia; C V Taylor; I A Watson; A A Lammertsma; R Lambrecht; J Waxman; T Jones; A A Epenetos
Journal: Int J Cancer Date: 1991-02-01 Impact factor: 7.396

Review 2. Chemical brain anatomy in schizophrenia.

Authors: G Sedvall; L Farde
Journal: Lancet Date: 1995-09-16 Impact factor: 79.321

3. Performance comparison of a state-of-the-art neuro-SPET scanner and a dedicated neuro-PET scanner.

Authors: D L Bailey; F Zito; M C Gilardi; A R Savi; F Fazio; T Jones
Journal: Eur J Nucl Med Date: 1994-05

4. A functional neuroanatomy of hallucinations in schizophrenia.

Authors: D A Silbersweig; E Stern; C Frith; C Cahill; A Holmes; S Grootoonk; J Seaward; P McKenna; S E Chua; L Schnorr
Journal: Nature Date: 1995-11-09 Impact factor: 49.962

5. Investigation of the opioid system in absence seizures with positron emission tomography.

Authors: P A Bartenstein; J S Duncan; M C Prevett; V J Cunningham; D R Fish; A K Jones; S K Luthra; G V Sawle; D J Brooks
Journal: J Neurol Neurosurg Psychiatry Date: 1993-12 Impact factor: 10.154

6. Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy.

Authors: M A Flower; A al-Saadi; C L Harmer; V R McCready; R J Ott
Journal: Eur J Nucl Med Date: 1994-06

7. Pharmacokinetics of the 13C labeled anticancer agent temozolomide detected in vivo by selective cross-polarization transfer.

Authors: D Artemov; Z M Bhujwalla; R J Maxwell; J R Griffiths; I R Judson; M O Leach; J D Glickson
Journal: Magn Reson Med Date: 1995-09 Impact factor: 4.668

8. Technetium-94m-teboroxime: synthesis, dosimetry and initial PET imaging studies.

Authors: R J Nickles; A D Nunn; C K Stone; B T Christian
Journal: J Nucl Med Date: 1993-07 Impact factor: 10.057

9. Changes in central opioid receptor binding in relation to inflammation and pain in patients with rheumatoid arthritis.

Authors: A K Jones; V J Cunningham; S Ha-Kawa; T Fujiwara; S K Luthra; S Silva; S Derbyshire; T Jones
Journal: Br J Rheumatol Date: 1994-10

10. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy.

Authors: K S Pentlow; M C Graham; R M Lambrecht; N K Cheung; S M Larson
Journal: Med Phys Date: 1991 May-Jun Impact factor: 4.071

17 in total

Review 1. Aspects of PET imaging relevant to the assessment of striatal transplantation in Huntington's disease.

Authors: L Besret; A L Kendall; S B Dunnett
Journal: J Anat Date: 2000-05 Impact factor: 2.610

2. Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging.

Authors: Bertrand Tavitian; Stéphane Marzabal; Valérie Boutet; Bertrand Kühnast; Salvatore Terrazzino; Marinette Moynier; Frédéric Dollé; Jean Robert Deverre; Alain R Thierry
Journal: Pharm Res Date: 2002-04 Impact factor: 4.200

Review 3. Characterizing tumors using metabolic imaging: PET imaging of cellular proliferation and steroid receptors.

Authors: D A Mankoff; F Dehdashti; A F Shields
Journal: Neoplasia Date: 2000 Jan-Apr Impact factor: 5.715

Review 4. Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors: P M Price; M M Green
Journal: Br J Radiol Date: 2011-03-22 Impact factor: 3.039

Review 5. [Imaging procedures for giant cell arteritis (Horton's disease)].

Authors: T A Bley; I Brink; M Reinhard
Journal: Ophthalmologe Date: 2006-04 Impact factor: 1.059

Review 6. Small animal imaging facility: new perspectives for the radiologist.

Authors: R Grassi; C Cavaliere; S Cozzolino; L Mansi; S Cirillo; G Tedeschi; R Franchi; P Russo; S Cornacchia; A Rotondo
Journal: Radiol Med Date: 2008-12-11 Impact factor: 3.469

7. Imaging the living human brain: magnetic resonance imaging and positron emission tomography.

Authors: N D Volkow; B Rosen; L Farde
Journal: Proc Natl Acad Sci U S A Date: 1997-04-01 Impact factor: 11.205

Review 8. The imaging science of positron emission tomography.

Authors: T Jones
Journal: Eur J Nucl Med Date: 1996-07

9. Effect of Animal Condition and Fluvoxamine on the Result of [(18)F]N-3-Fluoropropyl-2β-carbomethoxy-3β-(4-iodophenyl) Nortropane ([(18)F]FP-CIT) PET Study in Mice.

Authors: Kwang-Ho Shin; Su-A Park; Seog-Young Kim; Sang Ju Lee; Seung Jun Oh; Jae Seung Kim
Journal: Nucl Med Mol Imaging Date: 2011-11-26

10. P-Glycoprotein, not BCRP, Limits the Brain Uptake of [(18)F]Mefway in Rodent Brain.

Authors: Jae Yong Choi; Jin Sook Song; Minkyung Lee; Woon-Ki Cho; Jin Chung; Chul Hyoung Lyoo; Chul Hoon Kim; Jiae Park; Kyo Chul Lee; Kyeong Min Kim; Jee Hae Kang; Myung Ae Bae; Young Hoon Ryu
Journal: Mol Imaging Biol Date: 2016-04 Impact factor: 3.488